| 1 |
Maepa MB, Ely A, Kramvis A, Bloom K, Naidoo K, Simani OE, Maponga TG, Arbuthnot P. Hepatitis B Virus Research in South Africa. Viruses 2022;14:1939. [DOI: 10.3390/v14091939] [Reference Citation Analysis]
|
| 2 |
Wang XQ, Zerbato JM, Avihingsanon A, Fisher K, Schlub T, Rhodes A, Audsley J, Singh KP, Zhao W, Lewin SR, Palmer S. Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals. J Virol 2022;:e0058822. [PMID: 35916523 DOI: 10.1128/jvi.00588-22] [Reference Citation Analysis]
|
| 3 |
Heath RD, Syed A, Khalaf SA, Tahan V. HIV-HBV Co-infection, Clinical Concerns. Human Viruses: Diseases, Treatments and Vaccines 2021. [DOI: 10.1007/978-3-030-71165-8_20] [Reference Citation Analysis]
|
| 4 |
Nie Y, Deng X, Lan Y, Li L, Li F, Hu F. Comparison and Correlation of Genetic Variability of the HBV Pre-S Region in HIV/HBV Co-Infected Patients: Quasispecies Perspective. Infect Drug Resist 2020;13:4327-34. [PMID: 33293836 DOI: 10.2147/IDR.S278415] [Reference Citation Analysis]
|
| 5 |
Tamandjou Tchuem CR, Brandt L, Nel ER, Cotton MF, Matthews P, Kaindjee-Tjituka F, Preiser W, Andersson MI. Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia. PLoS One 2020;15:e0238839. [PMID: 32915862 DOI: 10.1371/journal.pone.0238839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 6 |
Nie Y, Deng XZ, Lan Y, Li F, Hu FY. Pre-S Deletions are Predominant Quasispecies in HIV/HBV Infection: Quasispecies Perspective. Infect Drug Resist 2020;13:1643-9. [PMID: 32606815 DOI: 10.2147/IDR.S255473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 7 |
Hu J, Liu K, Luo J. HIV-HBV and HIV-HCV Coinfection and Liver Cancer Development. Cancer Treat Res 2019;177:231-50. [PMID: 30523627 DOI: 10.1007/978-3-030-03502-0_9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 8 |
Li D, Chen Q, Tao C. BCP/PC mutation prevalence and their association with HBV replication in HIV/HBV co-infected patients. Arch Virol 2018;163:2829-33. [PMID: 29948380 DOI: 10.1007/s00705-018-3900-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 9 |
Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin SR. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS 2017;31:2035-52. [PMID: 28692539 DOI: 10.1097/QAD.0000000000001574] [Cited by in Crossref: 124] [Cited by in F6Publishing: 134] [Article Influence: 20.7] [Reference Citation Analysis]
|
| 10 |
Li J, Dou D, Li P, Luo W, Lv W, Zhang C, Song X, Yang Y, Zhang Y, Xu Y, Xiao F, Wei Y, Qin J, Li H, Yang X. PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population. Tumour Biol 2017;39:1010428317706914. [PMID: 28714367 DOI: 10.1177/1010428317706914] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
